Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC411601a,1b-dihomo Prostaglandin E2CAS: 26198-80-1纯度: >98.00%
A rare PUFA biosynthesized from adrenic acid
- GC4116415(R)-15-methyl Prostaglandin D2CAS: 210978-26-0纯度: >95.00%
A potent, selective agonist for the CRTH2/DP 2 receptor
- GC4116515(R)-15-methyl Prostaglandin E2CAS: 55028-70-1纯度: >98.00%
A prodrug for 15(S)-15-methyl PGE 2
- GC4116715(S)-15-methyl Prostaglandin E2CAS: 35700-27-7纯度: >98.00%
A potent, metabolically stable analog of PGE 2
- GC4116815-cyclohexyl pentanor Prostaglandin F2αCAS: 58611-97-5纯度: >96.00%
A PGF 2α analog resistant to 15-hydroxy PGDH metabolism
- GC41170Prostaglandin D2 methyl esterCAS: 49852-81-5纯度: >97.00%
A more lipid-soluble, cell-permeable prodrug form of PGD 2
- GC41174Pinane Thromboxane A2CAS: 71111-01-8纯度: >98.00%
A TP receptor antagonist and inhibitor of TX synthase
- GC41192(±)13-HDHACAS: 90780-53-3纯度: >98.00%
An autoxidation product of DHA and potential marker of oxidative stress
- GC41193(±)14-HDHACAS: 87042-40-8纯度: >98.00%
An autoxidation product of DHA and potential marker of oxidative stress
- GC41196(±)16-HDHACAS: 90780-51-1纯度: >98.00%
An autoxidation product of DHA and potential marker of oxidative stress
- GC41197(±)17-HDHACAS: 90780-52-2纯度: >98.00%
An autoxidation product of DHA and potential marker of oxidative stress
- GC41198(±)17-HDHA MaxSpec® StandardCAS: 90780-52-2纯度: >98.00%
An autoxidation product of DHA and potential marker of oxidative stress
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41160 | 1a,1b-dihomo Prostaglandin E2 | 26198-80-1 | >98.00% | |
A rare PUFA biosynthesized from adrenic acid | ||||
| GC41161 | 20-ethyl Prostaglandin E2 | 37492-24-3 | >97.00% | |
A PGE 2 analog | ||||
| GC41164 | 15(R)-15-methyl Prostaglandin D2 | 210978-26-0 | >95.00% | |
A potent, selective agonist for the CRTH2/DP 2 receptor | ||||
| GC41165 | 15(R)-15-methyl Prostaglandin E2 | 55028-70-1 | >98.00% | |
A prodrug for 15(S)-15-methyl PGE 2 | ||||
| GC41166 | 15(S)-15-methyl Prostaglandin D2 | 85280-90-6 | >95.00% | |
A stable PGD 2 synthetic analog | ||||
| GC41167 | 15(S)-15-methyl Prostaglandin E2 | 35700-27-7 | >98.00% | |
A potent, metabolically stable analog of PGE 2 | ||||
| GC41168 | 15-cyclohexyl pentanor Prostaglandin F2α | 58611-97-5 | >96.00% | |
A PGF 2α analog resistant to 15-hydroxy PGDH metabolism | ||||
| GC41169 | Lipoxin B4 methyl ester | 97589-07-6 | >95.00% | |
A lipid soluble prodrug of LXB 4 | ||||
| GC41170 | Prostaglandin D2 methyl ester | 49852-81-5 | >97.00% | |
A more lipid-soluble, cell-permeable prodrug form of PGD 2 | ||||
| GC41171 | Prostaglandin E2 methyl ester | 31753-17-0 | >98.00% | |
A lipid soluble PGE 2 analog | ||||
| GC41173 | 15(R)-Pinane Thromboxane A2 | 71154-83-1 | >98.00% | |
An epimer of PTA 2 | ||||
| GC41174 | Pinane Thromboxane A2 | 71111-01-8 | >98.00% | |
A TP receptor antagonist and inhibitor of TX synthase | ||||
| GC41178 | Lythrine | 5286-10-2 | >95.00% | |
An alkaloid | ||||
| GC41185 | MAGL Inhibitor Compound 23 | 2324160-91-8 | >95.00% | |
An inhibitor of MAGL | ||||
| GC41188 | 3-oxo Stearic Acid | 16694-29-4 | >90.00% | |
A bacterial β-keto fatty acid intermediate | ||||
| GC41189 | Ricinelaidic Acid | 540-12-5 | >98.00% | |
An LTB 4 antagonist | ||||
| GC41191 | (±)13(14)-EpDPA | 895127-64-7 | >95.00% | |
A DHA epoxygenase metabolite | ||||
| GC41192 | (±)13-HDHA | 90780-53-3 | >98.00% | |
An autoxidation product of DHA and potential marker of oxidative stress | ||||
| GC41193 | (±)14-HDHA | 87042-40-8 | >98.00% | |
An autoxidation product of DHA and potential marker of oxidative stress | ||||
| GC41194 | (±)16(17)-EpDPA | 155073-46-4 | >90.00% | |
A DHA congener of (±)14(15)-EpETrE | ||||
| GC41196 | (±)16-HDHA | 90780-51-1 | >98.00% | |
An autoxidation product of DHA and potential marker of oxidative stress | ||||
| GC41197 | (±)17-HDHA | 90780-52-2 | >98.00% | |
An autoxidation product of DHA and potential marker of oxidative stress | ||||
| GC41198 | (±)17-HDHA MaxSpec® Standard | 90780-52-2 | >98.00% | |
An autoxidation product of DHA and potential marker of oxidative stress | ||||
| GC41199 | (±)19(20)-EpDPA | - | >98.00% | |
A DHA epoxygenase metabolite | ||||